A promising drug candidate is only the beginning. Before a medicine can reach patients, its active pharmaceutical ingredient (API)—the component responsible for its therapeutic effect—must be developed into a process that can reliably produce the material needed for further development and, eventually, commercial supply. Getting there requires scientists to do more than identify the right chemistry...

The Nordic countries have established a strong foundation for life sciences innovation, with world-class universities, accomplished researchers and close ties between academia and industry. The region has also nurtured a growing community of biotech entrepreneurs and specialized investors. Yet turning promising discoveries into successful companies remains a challenge...

Cities are where innovation takes root and industries grow. From Couvet, Switzerland, to Middletown, Delaware, USA; from Singapore to Taixing and Changzhou in China, WuXi AppTec’s global operations are becoming part of the innovation ecosystems around them. Each site is more than a standalone manufacturing facility. It is rooted in its local community, connected to the surrounding industrial ecosystem, and growing alongside the city where it operates...

Over the past decade, Barcelona has moved firmly onto Europe's biotech map. The region ranked second among the European biotech hubs assessed by CPHI, and has built a growing base of life sciences companies and research institutions. It also attracted increasing amounts of international capital. More importantly, those once relatively disconnected pieces of the ecosystem are increasingly working together...

The investment provides WuXi AppTec’s clients with large-scale spray drying manufacturing capability, alongside the site's oral solid dose and packaging operations...

Medicines begin with a scientific idea. But between an idea in a research laboratory and a medication reaching a patient lies a long chain of work—scientific, technical, operational, and regulatory.